Cellectar Biosciences, Inc. (CLRB) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $1.7K2011: $118.4K2012: $97.7K2013: $147.8K2014: $29.6K2015: $58.5K2016: $72.3K2017: $346.7K2018: $385.0K2019: $24.5K2020: $62.4K2021: $141.4K2022: $226.0K2023: $864.0K2024: $104.2K2025: $5.9K$5.9K
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$5.9K-94.4%
2024$104.2K-87.9%
2023$864.0K+282.4%
2022$226.0K+59.9%
2021$141.4K+126.7%
2020$62.4K+154.1%
2019$24.5K-93.6%
2018$385.0K+11.0%
2017$346.7K+379.9%
2016$72.3K+23.6%
2015$58.5K+97.7%
2014$29.6K-80.0%
2013$147.8K+51.3%
2012$97.7K-17.5%
2011$118.4K+7067.7%
2010$1.7K